1
Memantine for Epileptic Encephalopathy
Condition(s):Epileptic Encephalopathy, Childhood-OnsetLast Updated:March 11, 2022Completed
Memantine Hydrochloride: 270 Clinical Trials, Page 1 of 27
Hide Studies Not Open or Pending
2
Effect of Memantine on ERP in Early Schizophrenia and Healthy Subjects
Condition(s):SchizophreniaLast Updated:December 14, 2015Unknown status
3
Down Syndrome Memantine Follow-up Study
Condition(s):Down Syndrome; Intellectual DisabilityLast Updated:April 5, 2022Completed
4
Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients
Condition(s):Bipolar DisorderLast Updated:October 3, 2019Unknown status
5
Memantine Treatment in Alzheimer’s Disease Patients
Condition(s):Alzheimer DiseaseLast Updated:May 30, 2017Unknown status
6
Effect of Early Memantine Administration on Outcome of Patients With Moderate to Severe Traumatic Brain Injury
Condition(s):Traumatic Brain InjuryLast Updated:September 8, 2022Active, not recruiting
7
Effect of Memantine on Cognitive Impairment in Patients With Epilepsy
Condition(s):EpilepsyLast Updated:June 4, 2020Completed
8
Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
Condition(s):Malignant Central Nervous System Neoplasm; Primary Central Nervous System NeoplasmLast Updated:June 7, 2022Recruiting
9
A Phase – IIa – IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCD
Condition(s):Sickle Cell DiseaseLast Updated:November 1, 2019Unknown status
10
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger’s Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Condition(s):Autism Spectrum Disorder (ASD); Autism; Autistic Disorder; Asperger’s Disorder; Asperger’s; Pediatric Autism; Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)Last Updated:August 7, 2014Completed